SCHEMBL141125

SCHEMBL141125

COc1cc(C(=O)c2c(N)sc3c2CCCC3)ccc1C

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.66
ALDH1A1 P00352 6/20 0.66
TDP1 Q9NUW8 1/20 0.61
HPGD P15428 5/20 0.60
GAA P10253 2/20 0.60
LMNA P02545 1/20 0.60
FLT3 P36888 3/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
RECQL P46063 1/20 0.55
ADORA1 P30542 1/20 0.54
HSD17B10 Q99714 5/20 0.52
KDM4E B2RXH2 4/20 0.52
ALOX15 P16050 4/20 0.52
MAPK1 P28482 2/20 0.52
USP2 O75604 1/20 0.50
TP53 P04637 1/20 0.49
THRB P10828 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL135885 0.91 MEN1 (0.65) MAPTALDH1A1TDP1HPGDGAA
SCHEMBL4060800 0.82 TDP1 (0.71) MAPTALDH1A1TDP1HPGDGAA
SCHEMBL136844 0.81 TDP1 (0.74) MAPTALDH1A1TDP1HPGDGAA
SCHEMBL3777713 0.81 TDP1 (0.69) MAPTALDH1A1TDP1HPGDGAA
SCHEMBL135616 0.81 MAPT (0.63) MAPTALDH1A1TDP1HPGDGAA
SCHEMBL135846 0.80 TDP1 (0.72) MAPTALDH1A1TDP1HPGDGAA
SCHEMBL135664 0.80 ALDH1A1 (0.73) MAPTALDH1A1TDP1HPGDGAA
SCHEMBL4060747 0.80 TDP1 (0.67) MAPTALDH1A1TDP1HPGDGAA
SCHEMBL140059 0.80 MAPT (1.00) MAPTALDH1A1TDP1HPGDGAA
SCHEMBL134640 0.79 MEN1 (0.67) MAPTALDH1A1TDP1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430029-B1 THIENO[2,3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS UNIV LEUVEN KATH (BE) 2018-01-10 EP disclosed
US-9499563-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2016-11-22 US disclosed
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS CISTIM LEUVEN VZW (BE) 2014-10-02 US disclosed
US-8785638-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2014-07-22 US disclosed
EP-2430029-A1 THIENO [2, 3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS Katholieke Universiteit Leuven (BE) 2012-03-21 EP disclosed
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2012-03-08 US disclosed
WO-2010130842-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2010-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS MAPT 2061/4885ALDH1A1 1925/4885TDP1 928/4885
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS MAPT 2061/4885ALDH1A1 1925/4885TDP1 928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.